The Efficacy and Safety of Rivaroxaban and Dalteparin in the Treatment of Cancer Associated Venous Thrombosis
Crossref DOI link: https://doi.org/10.1007/s12288-017-0895-8
Published Online: 2017-10-27
Published Print: 2018-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chaudhury, Ateefa
Balakrishnan, Asha
Thai, Christy
Holmstrom, Bjorn
Nanjappa, Sowmya
Ma, Zhenjun
Jaglal, Michael V.
License valid from 2017-10-27